|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
NeuroPace, Inc.
| | | Phone: | (866) 726-3876 | Year Established: | 1997 | Main Contact: | Frank M. Fischer, CEO | | Other Contacts: | Debra L. Smolley, VP, QA & Manufacturing Operations Isabella R. Abati, VP, RA Martha J. Morrell, MD, CMO Rebecca L. Kuhn, CFO & VP, Finance and Administration
| | Company Description | NeuroPace designs, develops, manufacturers and intends to market implantable devices for the treatment of neurological disorders. The company’s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately one percent of the population worldwide. An estimated 30-40 percent of the 65 million people worldwide (including nearly three million Americans) with epilepsy experience uncontrolled seizures. In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling neurological disorders that negatively impact quality of life for millions of patients throughout the world. | |
|
|
|
|
|